Achira

Executive Summary

Achira is a San Francisco-based biotechnology company pioneering atomistic foundation simulation models to revolutionize drug discovery. By integrating geometric deep learning, physics, quantum chemistry, and statistical mechanics, Achira develops advanced potentials and generative models that enable accurate synthetic dataset generation. This approach transforms drug discovery into an inverse design problem, potentially accelerating the identification of novel therapeutics. The company's technology aims to scale simulation models to produce large, high-quality datasets, addressing key bottlenecks in traditional drug development. While Achira operates in the competitive AI-driven drug discovery space, its unique blend of multiscale modeling and machine learning positions it as a potential leader in computational biophysics.

Upcoming Catalysts (preview)

• Q3 2026Pharmaceutical Partnership or Licensing Deal40% success
• Q3 2026Series A Funding Announcement50% success
• Q4 2026Peer-Reviewed Publication Demonstrating Model Accuracy60% success